Calycosin Suppresses Epithelial Derived Initiative Key Factors and Maintains
Yu
Introduction
Atopic dermatitis (AD) is one of the most common human skin diseases and now a major health problem worldwide. The development of AD is mainly attributed to geneticpolymorphisms, skin barrier dysfunction, environmental exposures, and host immune dysregulation [1] . Currently, established therapeutic therapies for AD is mainly by topical glucocorticosteroids, however, bad client compliance and low prescription rates greatly restricted the use of drugs [2] . Therefore, potent natural-derived compounds have been searched to treat AD in recent years.
initial stage of sensitization. Calycosin was able to inhibit the degree of ear swelling and ear histopathological level in mice [3] . However, the underlying mechanisms of calycosin have not been illustrated.
Investigations suggest that epithelium play active roles in AD. Firstly, the epithelium serves as a barrier by means of tight junctions (TJs) formation, which seals off the paracellular space, and possesses a gate function that selectively regulates the passage of ions and molecules [4, 5] . Among different TJ proteins, occludin and ZO-1 are predominantly involved protein of TJs, is most ubiquitously expressed at the apicalmost basolateral membranes and is the most reliable marker for TJs [9] . ZO-1 is considered as a scaffolding protein, linking TJ for occludin to be localized at TJs [10] . Disrupting either the expression or the distribution of ZO-1 leads to disruption of TJ assembly [11] . Moreover, disturbed skin barrier function such et al. reported that the expressions of occludin and ZO-1 were decreased in the atopic group by immunohistochemistry in experimental AD model in dogs [14] . allergens, viruses, and environmental pollutants that contribute to the pathogenesis of AD. In response to allergen triggers, the epithelium secretes various cytokines that are strongly increases in AD patients, which can be used as a biomarker of AD severity and particularly has recently been attributed to the epithelial "alarmin" defense system [20] . Furthermore, the mechanism of drug action from the perspective of epithelial cell function.
recognizes pathogen-associated microbial patterns from microbial and viral products and one of the most important transcription factors known to regulate the expressions of genes pathways are involved in the disruption of TJ proteins is still unknown. Our previous studies have demonstrated that administering of calycosin at the early pathological process. As stated above, epithelial cells play a key role in early stage of allergic calycosin attenuating AD from the perspective of epithelial cell function.
Materials and Methods

Chemicals Animals and cells
conditions at 18 C-25 2 .
Initial stage of AD model in vivo
applied as vehicle control (control group). FITC treated mice were administered once daily with calycosin C for 15 min.
Cell culture and treatment in vitro
HaCaT cells were seeded into 6-well plates at a density of 1×10 
Results
Calycosin inhibited expressions of initiative key factors in the initial stage of mice AD model
calycosin intragastrically 2 days before treatment with FITC until day 3 of the model. The 
Calycosin attenuated FITC-induced dysregulation of TJs in vivo
To determine whether the physiological changes in the epithelium barrier were accompanied by altered distribution of TJs, we analyzed the epithelial connection by TEM and clearly between adjacent cell membranes, forming a complete epithelial tissue structure in and ZO-1 protein levels were reduced obviously in mice after FITC indution. Treatment with
Calycosin suppressed expressions of initiative key factors in HaCaT cells in vitro Calycosin ameliorated LPS-induced dysregulation of TJs in HaCaT cells
in vivo effect of calycosin on TJs in HaCaT cells. Cells were pretreated with calycosin for 6 h, and 
TLR4 and its downstream molecules were regulated by calycosin in vivo
could be inhibited by calycosin in the initial stage of AD in mouse model, we tested the provide one possible mechanism that calycosin attenuated epithelial TJs disruption and initial stage of AD model.
TLR4 signaling activation was inhibited by calycosin in HaCaT cells in vivo, it was demonstrated that pretreatment with calycosin molecular operating environment (MOE) docking module showed that calycosin extended
Arg-264 and Asn-339, these interactions helped calycosin and to anchor in the binding site of function. 
Calycosin promoted the TJs expressions and inhibited the initiative key factors mainly by inhibiting NF-kB activation
Discussion
Epithelial integrity is compromised during the pathological process of AD and increasing barrier disruption may contribute to facilitate allergens to gain access to immune cells. The intact function of epithelial barrier is mainly determined by TJs, which function as a physical barrier between the external milieu and the internal milieu. It is well-documented that occludin and ZO-1 play important roles in regulating epithelial barrier disruption [6] [7] [8] . The
In an experimental AD model of dogs, TJs (mostly ZO-1 and occludin) are defective [14] . showed that TJs were dysregulated in the initial stage AD model of mice. However, calycosin
The epithelial cell barrier disruption is enhanced following stimulation by a variety gram-negative bacteria that can stimulates mononuclear cells and neutrophils to secrete connection damage in HaCaT cells, being in agreement with a previous literature in Caco- in vivo occludin and ZO-1 in HaCaT cells. Accordingly, calycosin protected the epithelial barrier function both in vivo and in vitro.
The epithelium responds to various environmental factors by releasing key cytokines inhibitory effects on the secretions and expressions of these initiative key factors in HaCaT cells.
epithelial barrier dysfunction and the increase of epithelial paracellular permeability to noxious luminal substances have been closely associated with increases in pro-allergic cytokines upon AD [42] . However, there the barrier function in human epithelial cells [43] . Meanwhile, the increased expression of 33 release may be associated with epithelium barrier dysregulation, but the relationship increasing TJs expressions still needs in-depth studies.
in vitro and in vivo. Moreover, 
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